Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways

Details for Australian Patent Application No. 2009265753 (hide)

Owner Institut National De La Sante Et De La Recherche Medicale (INSERM)

Inventors Caligiuri, Giuseppina; Nicoletti, Antonino

Agent Davies Collison Cave

Pub. Number AU-A-2009265753

PCT Pub. Number WO2010/000756

Priority 09305116.7 09.02.09 EP; 08305361.1 30.06.08 EP

Filing date 30 June 2009

Wipo publication date 7 January 2010

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/000756 Priority application(s): WO2010/000756

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009265760-Combinations comprising mGluR modulators for the treatment of parkinson's disease

2009265745-5-phenyl-isoxazole-3-carboxamides modulating Hsp90 with antitumoral activities